Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 27 Oct 2026

DRREDDY, full dossier

Dr Reddy's Laboratories reported a consolidated net profit of Rs 913.4 crore for the September quarter, down from Rs 1,426.8 crore in the corresponding quarter last year.

4 publishers have reported this development. Each act of reporting is below, cited.

The record

Dr Reddy's Laboratories reported a consolidated net profit of Rs 913.4 crore for the September quarter, down from Rs 1,426.8 crore in the corresponding quarter last year.

zeebiz.com26 Oct 2026

Dr Reddy's Labs reported a 36 per cent YoY fall in net profit to Rs 913 crore, while revenue declined nearly 2 per cent on a yearly basis to Rs 8,670.8 crore for the quarter ended September 30, 2026.

businesstoday.in26 Oct 2026

Dr Reddy's Laboratories reported a 36 per cent year-on-year decline in Q2 net profit.

Dr Reddy's Laboratories reported a 31.3% year-on-year decline in consolidated net profit for the September quarter, with net profit falling to Rs 925 crore from Rs 1,347 crore a year earlier.

ndtvprofit.com23 Oct 2026

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.